SARS-CoV-2 antibody responses in patients with acute leukaemia
| Errataetall: |
CommentOn: Leukemia. 2020 Nov;34(11):3047-3049. - PMID 32855439 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Leukemia - 35(2021), 1 vom: 11. Jan., Seite 289-292 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
O'Nions, J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 11.01.2021 Date Revised 14.09.2021 published: Print-Electronic CommentOn: Leukemia. 2020 Nov;34(11):3047-3049. - PMID 32855439 Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41375-020-01103-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318645645 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318645645 | ||
| 003 | DE-627 | ||
| 005 | 20231225165803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-020-01103-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM318645645 | ||
| 035 | |a (NLM)33299142 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a O'Nions, J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 antibody responses in patients with acute leukaemia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.01.2021 | ||
| 500 | |a Date Revised 14.09.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Leukemia. 2020 Nov;34(11):3047-3049. - PMID 32855439 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 700 | 1 | |a Muir, L |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, J |e verfasserin |4 aut | |
| 700 | 1 | |a Rees-Spear, C |e verfasserin |4 aut | |
| 700 | 1 | |a Rosa, A |e verfasserin |4 aut | |
| 700 | 1 | |a Roustan, C |e verfasserin |4 aut | |
| 700 | 1 | |a Earl, C |e verfasserin |4 aut | |
| 700 | 1 | |a Cherepanov, P |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, R |e verfasserin |4 aut | |
| 700 | 1 | |a Khwaja, A |e verfasserin |4 aut | |
| 700 | 1 | |a Jolly, C |e verfasserin |4 aut | |
| 700 | 1 | |a McCoy, L E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 35(2021), 1 vom: 11. Jan., Seite 289-292 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:1 |g day:11 |g month:01 |g pages:289-292 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-020-01103-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2021 |e 1 |b 11 |c 01 |h 289-292 | ||